Chemotherapy-Eluting Intraperitoneal Implants for Advanced Stage Ovarian Cancer Treatment
The objective of this work was to develop an implant for sustained abdominal chemotherapy delivery, intraperitoneal (IP) chemotherapy. IP chemotherapy has improved survival in ovarian cancer (OC) patients, but its adoption has suffered due to resource requirements and dose-limiting toxicities. We pr...
Main Author: | Subramanyam, Kriti S. |
---|---|
Other Authors: | Cima, Michael J. |
Format: | Thesis |
Published: |
Massachusetts Institute of Technology
2022
|
Online Access: | https://hdl.handle.net/1721.1/139892 |
Similar Items
-
Comment on: hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
by: Shalini Venkatappa, et al.
Published: (2022-01-01) -
Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
by: Andrea Jewell, et al.
Published: (2018-09-01) -
Role of hyperthermic intraperitoneal chemotherapy in combination with an intraperitoneal port system in the treatment of patients with advanced ovarian cancer
by: V. V. Saevets, et al.
Published: (2022-01-01) -
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01) -
Intraperitoneal chemotherapy following refractory intravenous route in advanced ovarian cancer.
by: Shafiee MN,, et al.
Published: (2013)